ABP fundraising for Cancer Research Wales this Cardiff Half
ABP will be using their places in this Oysho Cardiff Half Marathon to fundraise for Cancer Research Wales.
ABP, which has five ports in South Wales – Newport, Cardiff, Barry, Port Talbot and Swansea – is an official partner of the half, and has encouraged its team of runners to donate to the charity, which is also the event’s associate charity partner, when signing up to take part.
Hannah Kitcher, Regional Communications Manager at ABP, said: “We’re incredibly proud to be lacing up our running shoes for the Cardiff Half Marathon in support of Cancer Research Wales. As approximately 1 in 2 people in the UK will be diagnosed with cancer at some point in their lifetime, it’s safe to say every single person will know someone who has been affected. With Cancer Research Wales as an official charity partner of the race, ABP colleagues are honoured to being playing a part in supporting their vital work in improving outcomes for people across Wales.”
Cancer Research Wales is the only cancer research charity in Wales. It’s dedicated to transforming the lives of cancer patients across the country.
Adam Fletcher, CEO at Cancer Research Wales, said: “We are hugely grateful to have support from the team at ABP for this year’s Cardiff Half Marathon. This commitment to fundraising for Cancer Research Wales is extremely timely as we are seeing an unprecedented level of demand for new cancer research in Wales this year. We are the only charity dedicated to funding cancer research here in Wales and our work is only possible because of our incredible supporters. This support from ABP will help us bring better treatment closer to home for patients across Wales.”
Matt Newman, Chief Executive at event organisers Run 4 Wales, added: “It’s fantastic to see two of our longstanding partners collaborate in this way. We’ve worked with both ABP and Cancer Research Wales across numerous Run 4 Wales events and it’s wonderful to see the ABP runners fundraising for such an incredible cause.”
